ArticleReproduction & fertility2025
Regulatory mechanism of ghrelin on testosterone secretion in type 1 diabetic rats.
Article in Reproduction & fertility, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abstract: Ghrelin, which is a hormone composed of 28 amino acids that is mainly produced in the stomach, is also secreted by Leydig cells in the testes of rats and humans. The hypothalamus regulates testosterone secretion by releasing gonadotropin-releasing hormone (GnRH), which stimulates the pituitary gland to release luteinizing hormone (LH). LH then prompts the testes to produce testosterone via the activity of steroidogenic acute regulatory protein (StAR). Consequently, ghrelin may play a regulatory role in gonadal function. Male Sprague-Dawley rats were randomly assigned to four groups: the control, ghrelin-treated, diabetic, and diabetic plus ghrelin treatment groups. After the rats were sacrificed, plasma samples were collected. Leydig cells were isolated and cultured with human chorionic gonadotropin (hCG, which is similar to LH and is used to stimulate Leydig cells to synthesize testosterone), 8-bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP, which is an activator of cyclic adenosine monophosphate-dependent protein kinase), or forskolin (an activator of adenylyl cyclase in a wide variety of cell types). Compared with normal treatment, ghrelin treatment in diabetic rats markedly increased plasma testosterone levels by 3.75-fold (P < 0.05), Leydig cell testosterone secretion by 2.8-fold (P < 0.05), GnRH-mediated LH release from the anterior pituitary by 2.95-fold (P < 0.05), and StAR expression by 1.96-fold (P < 0.05) in testicular Leydig cells. These findings indicated that ghrelin enhanced testosterone production in diabetic rats, which was partially achieved by the hypothalamic-pituitary-gonadal axis and StAR. This study emphasized the potential use of ghrelin as a treatment for improving testosterone levels and gonadal function in individuals with diabetes. Lay summary: This study explored how a hormone known as ghrelin (which is mainly produced in the stomach) may help in regulating testosterone levels. Researchers examined male rats in four groups, including diabetic rats treated with ghrelin, and discovered that ghrelin increased testosterone production in diabetic rats by improving the communication between the brain, pituitary gland, and testes. This hormone also helped specific cells in the testes to function more effectively. The diabetic rats treated with ghrelin exhibited notable increases in testosterone levels and improved hormone function. These findings suggest that ghrelin could potentially help to address hormonal imbalances related to diabetes and improve reproductive health. This research highlights the potential benefits of ghrelin in addressing hormonal imbalances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.